Lab On Chips Market Size, Share, Opportunities And Trends By Product (Reagents & Consumables, Instruments, Software & Services), By Technology (Microarray, Microfluidics, Tissue Biochip), By Application (Genomics & Proteomics, Diagnostics, Others), By End-User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, Others) And By Geography - Forecasts From 2025 To 2030

Updated on: Jan 10, 2025

The lab-on-chips market is expected to hold a significant market share during the forecast period.

Lab on Chips Market Trends:

A Lab-on-a-Chip is a device that integrates laboratory functions and helps to achieve automation and high-throughput screening. Lab on Chips is also known as Micro-Total Analytical System. It has several advantages. It Helps in system compactness; lower fabrication costs; better process controls due to faster response to the system; lower analysis time; and helping in increasing automation capabilities. The application of lab on chips is increasing in different fields of life because of its advantages. For example, from detecting breast cancer to screening for HIV, and surviving serious diseases, all of it is done with the help of this chip.

The growth of the lab-on-a-chip market can also be substantiated by the increasing use of the chip in the health sector due to the widespread growth of point-of-care testing and the chip’s potential use in protein crystallization studies and DNA or RNA screening. Additionally, the rise in personalized medicine, drug delivery, and life science research, the need for high diagnostics, and increased government funding have also supported the trend in its growth.

The “Lab on Chips Market – Forecasts from 2019 to 2024” is an exhaustive study of this niche technology market which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by product, technology, application, end-user, and geography.

The lab on chips market has been segmented based on the product, technology, application, end-user, and geography. Based on product the market has been segmented into Reagents & Consumables, Instruments, and Software & Services. By technology, the market is classified as Microarray, Microfluidics, and Tissue Biochip. By application, the market has been classified into Genomics & Proteomics, Diagnostics, and Others. By end-user, the market has been classified as Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others.

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the lab on chips market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the lab on chips market.

Lab on Chips Market Segmentation:

• By Product

• • Reagents & Consumables
  • Instruments
  • Software & Services
• By Technology
• • Microarray
  • Microfluidics
  • Tissue Biochip
• By Application

• • Genomics & Proteomics
  • Diagnostics
  • Others
• By End-User

• • Hospitals & Clinics
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others
• By Geography

• • North America

• • • USA
    • Mexico
    • Canada

• • South America

• • • Brazil
    • Argentina
    • Others

• • Europe

• • • United Kingdom
    • Germany
    • France
    • Spain
    • Others

• • Middle East and Africa

• • • Israel
    • Saudi Arabia
    • Others

• • Asia Pacific

• • • China
    • Japan
    • South Korea
    • India
    • Others

1. INTRODUCTION

1.1. MARKET OVERVIEW

1.2. MARKET DEFINITION

1.3. SCOPE OF THE STUDY

1.4. CURRENCY

1.5. ASSUMPTIONS

1.6. BASE, AND FORECAST YEARS TIMELINE

2. RESEARCH METHODOLOGY

2.1. RESEARCH DESIGN

2.2. SECONDARY SOURCES

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. MARKET SEGMENTATION

4.2. MARKET DRIVERS

4.3. MARKET RESTRAINTS

4.4. MARKET OPPORTUNITIES

4.5. PORTER’S FIVE FORCES ANALYSIS

4.5.1. BARGAINING POWER OF SUPPLIERS

4.5.2. BARGAINING POWER OF BUYERS

4.5.3. THREAT OF NEW ENTRANTS

4.5.4. THREAT OF SUBSTITUTES

4.5.5. COMPETITIVE RIVALRY IN THE INDUSTRY

4.6. LIFE CYCLE ANALYSIS - REGIONAL SNAPSHOT

4.7. MARKET ATTRACTIVENESS

5. LAB ON CHIPS MARKET BY PRODUCT

5.1. REAGENTS & CONSUMABLES

5.2. INSTRUMENTS

5.3. SOFTWARE & SERVICES

6. LAB ON CHIPS MARKET BY TECHNOLOGY

6.1. MICROARRAY

6.2. MICROFLUIDICS

6.3. TISSUE BIOCHIPS

7. LAB ON CHIPS MARKET BY APPLICATION

7.1. GENOMICS & PROTEOMICS

7.2. DIAGNOSTICS

7.3. OTHERS

8. LAB ON CHIPS MARKET BY END-USER

8.1. HOSPITALS & CLINICS

8.2. DIAGNOSTIC CENTERS

8.3. ACADEMIC & RESEARCH INSTITUTES

8.4. OTHERS

9. LAB ON CHIPS MARKET BY GEOGRAPHY

9.1. NORTH AMERICA

9.1.1. USA

9.1.2. CANADA

9.1.3. MEXICO

9.2. SOUTH AMERICA

9.2.1. BRAZIL

9.2.2. ARGENTINA

9.2.3. OTHERS

9.3. EUROPE

9.3.1. GERMANY

9.3.2. FRANCE

9.3.3. UNITED KINGDOM

9.3.4. SPAIN

9.3.5. OTHERS

9.4. MIDDLE EAST AND AFRICA

9.4.1. ISRAEL

9.4.2. SAUDI ARABIA

9.4.3. OTHERS

9.5. ASIA PACIFIC

9.5.1. CHINA

9.5.2. JAPAN

9.5.3. SOUTH KOREA

9.5.4. INDIA

9.5.5. OTHERS

10. COMPETITIVE INTELLIGENCE

10.1. COMPETITIVE BENCHMARKING AND ANALYSIS

10.2. STRATEGIES OF KEY PLAYERS

10.3. RECENT INVESTMENTS AND DEALS

11. COMPANY PROFILES

11.1. ABBOTT LABORATORIES

11.2. F. HOFFMANN-LA ROCHE LTD.

11.3. SIEMENS AG

11.4. VITAL DIAGNOSTICS

11.5. PERKIN ELMER

11.6. LEXINNOVA

11.7. FLUIDIGM

11.8. DANAHER

11.9. HORIBA

11.10. RANDOX LABORATORIES LTD.

LIST OF FIGURES

LIST OF TABLES

Abbott Laboratories

F. Hoffmann-La Roche Ltd.

Siemens AG

Vital Diagnostics

Perkin Elmer

Lexinnova

Fluidigm

Danaher

Horiba

Randox Laboratories Ltd.